Phase Ⅱ Clinical Trial of Influenza Virus Split Vaccine for Individuals Aged 60 Years and Above

NCT07327398 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

1200

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Influenza virus split vaccine (0.7mL/vial)
BIOLOGICAL: Influenza virus split vaccine

Sponsor

Shanghai Institute Of Biological Products